Can Afro-communitarianism serve as a viable ideology for addressing the human interaction challenge posed by the COVID-19 pandemic? The ongoing pandemic poses many challenges to the normal functioning of societies around the world. For example, it has caused problems ranging from social, economic, and political disruption to various forms of hardship, including pain, suffering, and millions of deaths. One problem that is not attracting sufficient attention is a disruption to human interaction that leads to isolation, depression, mental health, and emotional crises. This paper will investigate whether Afro-communitarianism can function as an ideological option for addressing this challenge. This ideology, in our opinion, can foster social integration and the type of informal solidarity that engenders emotionally helpful interactions among humans. We will also argue that Afro-communitarian orientation can overturn the individualistic tendencies that hamper efforts aimed at curtailing the spread of the coronavirus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657064PMC
http://dx.doi.org/10.3390/ijerph192114255DOI Listing

Publication Analysis

Top Keywords

human interaction
12
posed covid-19
8
covid-19 pandemic?
8
afro-communitarianism combating
4
combating challenge
4
challenge human
4
interaction posed
4
pandemic? afro-communitarianism
4
afro-communitarianism serve
4
serve viable
4

Similar Publications

Background: Currently, paradoxical findings exist regarding the level of functioning in individuals with Hikikomori (prolonged social withdrawal).

Aims: This systematic review aimed to clarify the functioning, disability, and health of individuals with Hikikomori and their families in comparison to those without Hikikomori.

Method: Relevant studies were searched from April 22 to 25, 2022, using MEDLINE, PsycINFO, Scopus, and two Japanese databases.

View Article and Find Full Text PDF

Drug-Drug Interaction Between Rifampicin and Albuvirtide: A Phase 1, Randomized, Open-Label Study.

J Clin Pharmacol

January 2025

Department of Pharmacy, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Albuvirtide (ABT) is a novel long-acting fusion inhibitor for human immunodeficiency virus type 1 (HIV-1), and may be co-administered with rifampicin (RIF) in patients concurrent with tubercle bacillus and HIV-1. This study was conducted to investigate the pharmacokinetic effect of co-administration of the two drugs. In the study, 24 healthy volunteers were randomized to receive ABT alone or with RIF.

View Article and Find Full Text PDF

The human visual nervous system excels at recognizing and processing external stimuli, essential for various physiological functions. Biomimetic visual systems leverage biological synapse properties to improve memory encoding and perception. Optoelectronic devices mimicking these synapses can enhance wearable electronics, with layered heterojunction materials being ideal materials for optoelectronic synapses due to their tunable properties and biocompatibility.

View Article and Find Full Text PDF

Fluorine-free organic framework polyelectrolyte membranes showing near frictionless ionic conductivities are gaining cognitive insights. However, the co-precipitation of COFs in the membranes often brings trade-offs to commission long-life electrochemical energy storage solutions. Herein, a durable and ionically miscible dual-ion exchange membrane based on triazine organic framework (TOF) is designed for alkaline redox flow batteries (RFB).

View Article and Find Full Text PDF

Traditional drug discovery methods such as wet-lab testing, validations, and synthetic techniques are time-consuming and expensive. Artificial Intelligence (AI) approaches have progressed to the point where they can have a significant impact on the drug discovery process. Using massive volumes of open data, artificial intelligence methods are revolutionizing the pharmaceutical industry.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!